Surgical Soft Tissue Forceps Market Report 2024

The surgical soft tissue forceps market size has grown strongly in recent years. It will grow from $1.2 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to factors such as an increase in surgical procedures, an aging population, advancements in surgical techniques, rising healthcare expenditure, the prevalence of chronic diseases, the expansion of healthcare infrastructure, and higher disposable income.

The surgical soft tissue forceps market size is expected to see strong growth in the next few years. It will grow to $1.72 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. For the forecast period, growth can be attributed to technological advancements, demand for minimally invasive surgery, regulatory compliance, a focus on patient safety, market expansion in emerging economies, a shift towards sustainable practices, telemedicine, and digital health. Major trends in the forecast period include advancements in materials, miniaturization, robotics and automation, customization and personalization, smart instruments, a focus on ergonomics, and the integration of telehealth.

The growth of the surgical soft tissue forceps market is expected to be driven by an increasing number of aesthetic procedures. These procedures, which aim to enhance physical appearance through elective medical treatments, whether surgical or non-surgical, have seen a rise due to societal beauty standards, greater accessibility, and the influence of social media. Surgical soft tissue forceps play a crucial role in such procedures by delicately handling and manipulating tissues, minimizing trauma, and ensuring precise placement during surgeries such as facelifts, rhinoplasties, and breast augmentations. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons reported a significant increase in cosmetic surgeries in the UK, marking a notable 102% rise from 2021, with 31,057 procedures performed. This trend underscores the driving force behind the growth of the surgical soft tissue forceps market.

Leading companies in the surgical soft tissue forceps market are focusing on innovating new generations of disposable bipolar forceps to expand their market presence in surgical precision products. These disposable bipolar forceps are essential for grasping, holding, and maneuvering delicate tissues while minimizing adhesion and charring. For instance, Carl Zeiss Meditec AG received FDA 510(k) clearance in October 2022 for MTLawton, a new disposable bipolar forceps made from a special copper-base alloy. This material significantly reduces tissue adhesion and charring during electrosurgical procedures, enhancing cautery-based hemostasis. The forceps feature an extended shaft that improves visibility in the surgical field, providing a clearer view of the coagulation area and thereby improving efficiency in electrosurgical procedures.

In January 2024, Stille AB, a Swedish firm specializing in the development and production of surgical instruments, purchased Fehling Instruments GmbH & Co. KG and its affiliated subsidiaries for $40.32 million. This acquisition aims to broaden Stille AB's range of premium medical instruments, focusing on specialized surgical fields such as open and minimally invasive procedures in cardiac, thoracic, neurosurgery, and spine surgery. Fehling Instruments GmbH & Co. KG, based in Germany, is known for manufacturing surgical instruments, including soft tissue forceps, enhancing Stille AB's capabilities in these critical surgical specialties.

Major companies operating in the surgical soft tissue forceps market are Medtronic plc, Johnson & Johnson MedTech, Medline Industries, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, CooperSurgical Inc., Cook Medical, Karl Storz GmbH And Co. KG, Integra LifeSciences Corporation, ConMed Corporation, KLS Martin Group, Aesculap Inc., Richard Wolf GmbH, Aspen Surgical Products Inc., Symmetry Surgical Inc., MedGyn Products Inc., Scanlan International Inc., Sklar Surgical Instruments, GPC Medical Ltd., Hayden Medical Inc., Millennium Surgical Corp., S Murray And Co Ltd., Surgmed Group, Lawton GmbH And Co. KG, Marina Medical Instruments Inc., Surgipro Inc., Surtex Instruments Ltd.

North America was the largest region in the surgical soft tissue forceps market in 2023. The regions covered in the surgical soft tissue forceps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical soft tissue forceps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Surgical soft tissue forceps are specialized tools used during operations to grasp, hold, and manipulate soft tissues with minimal damage. They feature fine tips and a gentle grip to carefully handle delicate tissues.

There are two main types of surgical soft tissue forceps disposable and reusable. Disposable forceps are intended for single use, typically made from cost-effective materials suitable for one procedure, particularly in environments where hygiene and contamination are critical, such as sterile settings or surgeries involving infectious diseases. These forceps are used in hospitals, clinics, and other medical facilities. End users include professionals in gynecology, general surgery, neurosurgery, plastic surgery, and other fields.

The surgical soft tissue forceps market research report is one of a series of new reports that provides surgical soft tissue forceps market statistics, including surgical soft tissue forceps industry global market size, regional shares, competitors with an surgical soft tissue forceps market share, detailed surgical soft tissue forceps market segments, market trends and opportunities, and any further data you may need to thrive in the surgical soft tissue forceps industry. This surgical soft tissue forceps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical soft tissue forceps market consists of sales of products such as adson forceps, deBakey forceps, bishop-harmon forceps, and brown-adson forceps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.